Brian W. Fox

905 total citations
35 papers, 721 citations indexed

About

Brian W. Fox is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Brian W. Fox has authored 35 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Brian W. Fox's work include Cancer therapeutics and mechanisms (8 papers), Carcinogens and Genotoxicity Assessment (5 papers) and DNA and Nucleic Acid Chemistry (4 papers). Brian W. Fox is often cited by papers focused on Cancer therapeutics and mechanisms (8 papers), Carcinogens and Genotoxicity Assessment (5 papers) and DNA and Nucleic Acid Chemistry (4 papers). Brian W. Fox collaborates with scholars based in United Kingdom, United States and Germany. Brian W. Fox's co-authors include Philip Bedford, William H. Prusoff, Julie A. Woods, Derek Crowther, Margaret Fox, Michael Lind, Nicholas Thatcher, Alan T. McGown, George R. Pettit and Timothy H. Ward and has published in prestigious journals such as Nature, JNCI Journal of the National Cancer Institute and Journal of Chromatography A.

In The Last Decade

Brian W. Fox

33 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian W. Fox United Kingdom	14	334	268	171	90	85	35	721
Janet S. Macpherson United Kingdom	16	385 1.2×	119 0.4×	333 1.9×	50 0.6×	65 0.8×	30	861
Theodore J. Boritzki United States	19	676 2.0×	244 0.9×	300 1.8×	68 0.8×	64 0.8×	32	1.0k
Joachim Blanz Germany	14	536 1.6×	183 0.7×	202 1.2×	40 0.4×	52 0.6×	31	967
Sartorelli Ac United States	13	393 1.2×	90 0.3×	157 0.9×	53 0.6×	82 1.0×	28	614
C. David Jones United States	16	235 0.7×	316 1.2×	131 0.8×	29 0.3×	66 0.8×	28	985
Martin Sweeney United States	17	523 1.6×	208 0.8×	117 0.7×	32 0.4×	113 1.3×	29	918
W R Laster United States	17	397 1.2×	175 0.7×	317 1.9×	20 0.2×	129 1.5×	42	957
G L Neil United States	19	548 1.6×	190 0.7×	169 1.0×	24 0.3×	74 0.9×	42	867
Shigeki Kashimoto Japan	14	339 1.0×	243 0.9×	185 1.1×	74 0.8×	53 0.6×	21	733
Tracy E. Strecker United States	22	462 1.4×	479 1.8×	235 1.4×	63 0.7×	165 1.9×	33	1.1k

Countries citing papers authored by Brian W. Fox

Since Specialization

Citations

This map shows the geographic impact of Brian W. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian W. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian W. Fox more than expected).

Fields of papers citing papers by Brian W. Fox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian W. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian W. Fox. The network helps show where Brian W. Fox may publish in the future.

Co-authorship network of co-authors of Brian W. Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Brian W. Fox. A scholar is included among the top collaborators of Brian W. Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian W. Fox. Brian W. Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Byrne, Barry J., Giancarlo Parenti, Benedikt Schoser, et al.. (2024). Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease. Frontiers in Neurology. 15. 1451512–1451512. 6 indexed citations

Claeys, Kristl G., Hani Kushlaf, Noemi Hummel, et al.. (2024). Minimal clinically important differences in six-minute walking distance in late-onset Pompe disease. Orphanet Journal of Rare Diseases. 19(1). 154–154. 5 indexed citations

Shohet, Simon, Jeff Castelli, Sheela Sitaraman, et al.. (2023). Therapeutic Role of Pharmacological Chaperones in Lysosomal Storage Disorders: A Review of the Evidence and Informed Approach to Reclassification. Biomolecules. 13(8). 1227–1227. 15 indexed citations

Fox, Brian W., et al.. (1997). Book Reviews. Botanical Journal of the Linnean Society. 124(2). 211–212. 1 indexed citations

Zhang, Xiu-Guo, Brian W. Fox, & John A. Hadfield. (1996). Preparation of Naturally Occurring Anthraquinones. Synthetic Communications. 26(1). 49–62. 6 indexed citations

Brown, Richard T., et al.. (1994). Synthesis of 2,6-dimethyl-1,4,4a,5,8,8a,9a,10a-octahydro-9,10-anthraquinone and its 2,7-dimethyl isomer.. Journal of Chemical Research Synopses. 220–221.

Woods, Julie A., et al.. (1993). Bioactivity and molecular modelling of diphenylsulfides and diphenylselenides. Bioorganic & Medicinal Chemistry. 1(5). 333–340. 82 indexed citations

McGown, Alan T., et al.. (1993). The suitability of carboplatin solutions for 14-day continuous infusion by ambulatory pump: An HPLC—dynamic FAB study. Journal of Pharmaceutical and Biomedical Analysis. 11(8). 723–727. 3 indexed citations

Fox, Brian W., et al.. (1992). Benzamide potentiation of the cytotoxicity of bifunctional galacticol in resistant P388 leukemia correlates with inhibition of DNA ligase II. Cancer Chemotherapy and Pharmacology. 30(4). 325–329. 3 indexed citations

10.

Jackson, H., et al.. (1992). A comparative binding of platinum anti-tumour compounds to plasma proteins in the rat (in vivo) and mouse (in vitro). Chemico-Biological Interactions. 85(2-3). 199–213. 18 indexed citations

11.

Fox, Brian W., et al.. (1990). Differential cytotoxicity of Combretastatins A1 and A4 in two daunorubicin-resistant P388 cell lines. Cancer Chemotherapy and Pharmacology. 26(1). 79–81. 126 indexed citations

12.

Lind, Michael, et al.. (1989). The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivo. Biochemical Pharmacology. 38(11). 1835–1840. 74 indexed citations

13.

McGown, Alan T., et al.. (1984). Collateral sensitivity of a methotrexate-resistant L1210 cell line to the vinca alkaloids. Cancer Chemotherapy and Pharmacology. 13(1). 43–46. 6 indexed citations

14.

Bedford, Philip & Brian W. Fox. (1982). Repair of DNA interstrand crosslinks after busulphan. Cancer Chemotherapy and Pharmacology. 8(1). 3–7. 28 indexed citations

15.

Carr, Francis J. & Brian W. Fox. (1981). DNA strand breaks and repair synthesis in Yoshida sarcoma cells with differential sensitivities to bifunctional alkylating agents and UV light. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 83(2). 233–249. 7 indexed citations

16.

Fox, Brian W. & M A Moore. (1979). Basis for cancer therapy. Pergamon eBooks. 4 indexed citations

17.

Fox, Brian W., et al.. (1975). Fractionation of mammalian DNA on DEAE-cellulose. Journal of Chromatography A. 107(1). 125–140. 1 indexed citations

18.

Fox, Brian W.. (1969). The sensitivity of a yoshida sarcoma to methylene dimethane sulphonate. International Journal of Cancer. 4(1). 54–60. 30 indexed citations

19.

Fox, Brian W. & Margaret Fox. (1967). Effect of methyl methanesulfonate on macromolecular biosynthesis in P388F cells.. PubMed. 27(11). 2234–9. 9 indexed citations

20.

Fox, Brian W. & William H. Prusoff. (1965). THE COMPARATIVE UPTAKE OF I-125-LABELED 5-IODO-2'-DEOXYURIDINE AND THYMIDINE-H3 INTO TISSUES OF MICE BEARING HEPATOMA-129.. PubMed. 25. 234–40. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact